Diabetes Treatment and Management

59 ta ish

EFFECT OF GLIFLOZINS ON RENAL DYSFUNCTION IN CHRONIC HEART FAILURE WITH ANEMIA
A. G. Gadaev, F. I. Khujakulova
MaqolaDiabetes Treatment and ManagementOriental Journal of Medicine and Pharmacology20230 iqtibos
ABI
THE ROLE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND GLIFLOZINS IN THE TREATMENT OF CHRONIC HEART FAILURE WITH ANEMIA
A. G. Gadaev, F. I. Khujakulova
MaqolaErythropoietin and Anemia TreatmentOriental Journal of Medicine and Pharmacology20230 iqtibos
ABI
QАNDLI DIАBET KАSАLLIGINI DAVOLASHDA FOYDALANILADIGAN SINTETIK DORI VOSITALARI VА ULАRNING KIMYOVIY TARKIBI
Go’yoxon Alidjonovna Mo’minova, Ibrohimjon Rahmonovich Asqarov
MaqolaDiabetes Treatment and ManagementJournal of Chemistry of Goods and Traditional Medicine20230 iqtibos
ABI
#150 Effect of dapagliflozin in patients with CKD depending on primary kidney disease
Sherzod Abdullaev, Botir Daminov, Olimkhon Sharapov
MaqolaDiabetes Treatment and ManagementNephrology Dialysis Transplantation20240 iqtibos
ABI
#206 The effect of dapagliflozin on anemia in patients with CKD
Sherzod Abdullaev, Ranokhon Igamberdieva
MaqolaDiabetes Treatment and ManagementNephrology Dialysis Transplantation20240 iqtibos
ABI
Prognostic significance of biomarkers in the early diagnosis of nephropathy in diabetes mellitius II type
Nilufar Akhmedova, Gulnoza Sulaymanova, Kamol Boltayev
MaqolaChronic Kidney Disease and DiabetesBIO Web of Conferences20240 iqtibos
ABI
Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2)
Ashot Avagimyan, Mohammad Sheibani, А. И. Трофименко +15
MaqolaDiabetes Treatment and ManagementInnovative medicine of Kuban20250 iqtibos
ABI
ON THE SIGNIFICANCE OF THE SCORE-2 RISK SCALE FOR CARDIOVASCULAR COMPLICATIONS AMONG PATIENTS WITH PREDIABETES
Shakhnоza Yusupova, Ruhsorakhon Abdurahmanova
MaqolaDiabetes, Cardiovascular Risks, and LipoproteinsMedical science of Uzbekistan20250 iqtibos
ABI
Nephroprotective treatment with dapagliflozin in patients with diabetic kidney disease
Olimkhon Sharapov, Sherzod Abdullaev
MaqolaDiabetes Treatment and ManagementNephrology and Dialysis20250 iqtibos
ABI
Evaluation of the efficacy of treatment using SGLT2 inhibitors in patients with acute myocardial infarction
Dilafruz Akhmedova, Раиса Тригулова
MaqolaDiabetes Treatment and ManagementAtherosclerosis20250 iqtibos
ABI
Prognosis of Hospitalizations of Patients with Different Phenotypes of Heart Failure in Type 2 Diabetes Mellitus
Раиса Тригулова, Alisher Ikramov, Dilafruz Akhmedova +3
MaqolaDiabetes Treatment and ManagementAmerican Heart Journal20250 iqtibos
ABI
Cardiovascular Outcomes of SGLT-2 Inhibitors in Hypertensive Patients With and Without Diabetes: A Retrospective Observational Study
Salar Sohail, Talat Bashir, Hajra Tariq +5
MaqolaDiabetes Treatment and ManagementCureus20250 iqtibos
ABI
#1796 The impact of metabolic syndrome components on renal function in patients with heart failure
Музаффар Илхомжон Асомов, Gulchehra Atakhodjayeva, Olimkhon Sharapov +1
MaqolaDiabetes Treatment and ManagementNephrology Dialysis Transplantation20250 iqtibos
ABI
QANDLI DIABET VA UNING ASORATLARI
Xodjaeva Muqaddas Sati – Maxamatovna,Abdamutova Mahliyo Hasanboy qizi
MaqolaDiabetes, Cardiovascular Risks, and LipoproteinsZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
ABI
CLINICAL EFFICACY OF SGLT2 INHIBITORS AND METFORMIN COMBINATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
M Rizayeva, M Axmedova
MaqolaDiabetes Treatment and ManagementScientific and Innovative Therapy20250 iqtibos
ABI
Central obesity and glycaemic control in newly diagnosed type 2 diabetes mellitus patients: evidence from Uzbekistan
Shukhrat Ziyadullaev, Shokhista Eshmuradova, Jonibek Kadirov +3
PreprintDiabetes, Cardiovascular Risks, and LipoproteinsResearch Square20250 iqtibos
ABI
Peptide drugs for obesity and type 2 diabetes mellitus: an overview of clinical trials
Haniyeh Barzgar, Darmadi Darmadi, Jabbarova Nafisa +2
Sharh maqolaDiabetes Treatment and ManagementClinica Chimica Acta20250 iqtibos
ABI
QANDLI DIABETDA HbA1c KO‘RSATKICHINING KLINIK AHAMIYATI
Yulduzxon Fayzullayeva, Maftuna Yusupova
MaqolaDiabetes, Cardiovascular Risks, and LipoproteinsQO‘QON UNIVERSITETI XABARNOMASI20260 iqtibos
ABI
Central obesity and glycaemic control in newly diagnosed type 2 diabetes mellitus patients: evidence from Uzbekistan
Shukhrat Ziyadullaev, Shokhista Eshmuradova, Jonibek Kadirov +3
MaqolaDiabetes, Cardiovascular Risks, and LipoproteinsBMC Endocrine Disorders20260 iqtibos
ABI
The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance
Mukhammadali Jumayev
MaqolaDiabetes Treatment and ManagementZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance
Mukhammadali Jumayev
MaqolaDiabetes Treatment and ManagementZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance
Mukhammadali Jumayev
MaqolaDiabetes Treatment and ManagementZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance
Mukhammadali Jumayev
MaqolaDiabetes Treatment and ManagementZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
Cost-Effectiveness of Empagliflozin in Patients with Chronic Heart Failureand Chronic Kidney Disease: A Systematic Review
Sultanbaeva Nargiza, Mukhamedova Shohista, Umarova Shakhnoz +1
MaqolaDiabetes Treatment and ManagementCurrent Cardiology Reviews20260 iqtibos
ABI
Clinical efficacy of SGLT2 inhibitors in chronic heart failure and chronic kidney disease: a systematic review and meta-analysis
Nargiza Sultanbaeva, Shohista Mukhamedova, Shakhnoz Umarova +1
MaqolaDiabetes Treatment and ManagementCurrent Cardiology Reviews20260 iqtibos
ABI